BioXcel Therapeutics, Inc. earnings per share and revenue

BTAI earnings per share for the last quarter are -0.32 USD whereas the estimation was -0.51 USD which accounts for 36.70% surprise. Company revenue for the same period amounts to 214.00 k USD despite the estimated figure of 1.33 M USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 966.92 k USD. Also watch annual changes over time to get a bigger picture of BTAI earnings per share and revenue dynamics.